Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
Study Identifier
M03-651
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
20+ years
Protocol Summary
The purpose of the study is to assess the long-term safety and tolerability of repeated
administration of adalimumab in Japanese subjects with rheumatoid arthritis.
Study Locations
Location
Status
Location
Tokyo, Metropolis, Japan
Status
Not applicable
Location
Aichi, Prefecture, Japan
Status
Not applicable
Location
Chiba, Prefecture, Japan
Status
Not applicable
Location
Ehime, Prefecture, Japan
Status
Not applicable
Location
Fukui, Prefecture, Japan
Status
Not applicable
Location
Fukuoka, Prefecture, Japan
Status
Not applicable
Showing {first} - {last} of {total} Results